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Purpose: To estimate the extent of familial aggregation of type 1 diabetes (T1D) and coag-
gregation of related chronic diseases and assess the relative contribution of environmental and 
genetic factors on the risks.
Patients and methods: This population-based study used the Taiwan National Health 
Insurance  database to reconstruct family structure and identify people with T1D and other 
chronic diseases between 1999 and 2015. Relative risks (RRs) for T1D and other chronic dis-
eases and heritability of T1D were estimated. Heritability was estimated using the polygenic 
liability model.
Results: Validation of family structure found the positive predictive value to be 98.7% 
for maternal links and 98.6% for paternal links. Having an affected twin, first-degree rela-
tive, or spouse was associated with an adjusted RR (95% CI) of 553.66 (427.59–716.89), 
32.49 (28.66–36.84), and 2.17 (0.31–15.40) for T1D, respectively. Based on the polygenic 
liability model, heritability, shared and non-shared contributions to T1D, and variances were 
66.50%, 10.86%, and 22.64%, respectively. A family history of T1D was associated with an 
RR (95% CI) of 1.51 (1.20–1.89) for rheumatoid arthritis, 1.66 (1.21–2.26) for Sjögren’s 
syndrome, 1.48 (1.09–2.01) for systemic lupus erythematosus, 1.24 (1.14–1.35) for simple 
goiter, 1.16 (1.04–1.31) for non-toxic nodular goiter, 1.61 (1.49–1.74) for thyrotoxicosis, 
1.78 (1.57–2.01) for acquired hypothyroidism, 1.66 (1.40–1.98) for thyroiditis, and 1.15 
(0.97–1.37) for epilepsy.
Conclusion: These data highlight the importance of the genetic contribution to T1D and confirm 
the coaggregation of autoimmune and metabolic diseases with T1D.
Keywords: type 1 diabetes mellitus, familial aggregation, co-aggregation, autoimmune dis-
eases, endocrine diseases
Introduction
Type 1 diabetes mellitus is an autoimmune disorder caused by the destruction of 
pancreatic β cells in people with a genetic predisposition, and it is characterized by 
absolute insulin deficiency.1,2 Although type 1 diabetes has a relatively low prevalence, 
epidemiologic studies have reported that the incidence of type 1 diabetes is increasing 
by 3% per year worldwide.3 It is one of the most common autoimmune diseases in 
childhood with an estimated incidence rate of 6.4/100,000 for 0- to 9-year-old Asians 
and Pacific Islanders.4 A recent population-based estimate of the incidence of type 1 
diabetes in Taiwan was 5.6/1,000,000 for 0- to 14-year-olds,5 with a two- to three-fold 
higher mortality rate than age-matched individuals.6
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Positive family history is one of the strongest risk fac-
tors for type 1 diabetes, and the genetic contribution to the 
susceptibility to type 1 diabetes is substantial.7 For example, 
the human leukocyte antigen (HLA) region has been found to 
be one of the major genetic determinants of type 1 diabetes.1,8 
Strong ethnic differences in the HLA haplotypes present 
in this region,9 such as those between European and East 
Asian populations,10 are likely to explain some of the large 
variations in the prevalence and incidence of type 1 diabetes. 
To date, heritability estimates for type 1 diabetes have been 
derived only for populations of European origin,11,12 and the 
results have suggested an additive genetic contribution of 
72%–88%. The heritability in East Asian populations has 
not been investigated to date. In addition, it is well known 
that type 1 diabetes coaggregates with other autoimmune 
diseases such as autoimmune thyroid disease and celiac 
disease.13 Recently, Chou et al reported that individuals with 
type 1 diabetes were more likely to develop epilepsy than 
controls,14 a finding that was later confirmed in a European 
cohort.15 Therefore, there may be a common root for type 1 
diabetes with these chronic conditions.
This nationwide study used data on the entire population 
of Taiwan in 2015 to construct nationwide genealogy linking 
to health information derived from a large comprehensive 
database. We aimed to estimate the relative risks (RRs) of 
type 1 diabetes in individuals with affected relatives of spe-
cific kinship, and assess the relative contribution of genetic, 
and shared and non-shared environmental factors to the 
susceptibility to type 1 diabetes. In addition, we estimated 
the RRs of other chronic diseases in people with a family 
history of type 1 diabetes.
Materials and methods
study population
Ethical approval was obtained from the Institutional Review 
Board of Chang Gung Memorial Hospital and the National 
Health Research Institute (IRB No 104-8042B), the data 
holder of the National Health Insurance (NHI) database. 
The NHI database was provided by the Administration of 
National Health Insurance, Ministry of Health and Welfare. 
The database is fully anonymized, and no trackable data 
were available. To protect confidentiality, the conduct of the 
research and use of the data within the database are restricted 
to the specialized data center operated by the administration. 
We constructed a cohort comprising all beneficiaries of the 
Taiwan NHI program who were registered in 2015 and had 
valid insurance status using data from the Registry for NHI 
beneficiaries.
The Taiwan NHI program was initiated in 1995 as a 
single-payer insurance system co-funded by the government, 
employers, and beneficiaries. As a single-payer system and as 
enrollment is required by law,16 almost all residents in Taiwan 
are enrolled, and the majority of medical facilities in Taiwan 
are contracted with the NHI to provide a comprehensive pack-
age of health care. The NHI database contains all registration 
and original claims data, including gender, date of birth, place 
of residence, details of insurance, family relationships, dates 
of inpatient and outpatient visits, medical diagnoses, medical 
expenditure, prescription details, examinations, operations, 
and procedures. All information in the database and other 
government-held data such as the death registry are linked 
using a unique personal identifier assigned to each resident 
in Taiwan. The personal identifier is encrypted; however, the 
identification remains unique for each beneficiary in the data-
base to facilitate internal and external linkage of records.
Methods of nationwide genealogy 
reconstruction
We have reported methods for genealogy reconstruction using 
family relationships recorded in the NHI database in our previ-
ous publications.17–19 The registry of beneficiaries records the 
insurance status of all people covered by the NHI program, 
and also contains information regarding relationships between 
the insured person (who paid the insurance fee) and his/her 
dependents. Both blood relatives and spouses are eligible as 
dependents of the insured. A birth certificate is required for 
a child to be registered as a dependent of their parents. The 
family identifiers and unique personal identifiers allowed 
us to establish family relationships (parents, offspring, full 
siblings, twins, and spouse). We used an algorithm to identify 
parent–offspring relationships indirectly and to maximize pos-
sible family links.17–19 Full siblings were defined as those with 
the same parents. Twins were defined as full siblings with the 
same date of birth (± 1 day). However, twin zygosity could not 
be derived from the database. Changes in residence, employ-
ment, insurance status (insurant or dependent), and relation-
ships between the insurant and dependents are recorded in 
the registry. Overall, there were ~364 million records in the 
registry in 2015. We used this dynamic nature to maximize 
the identification of possible family links by incorporating the 
entire registry of records from 1999 to 2015. We used family 
relationships to reconstruct genealogy. Overall, we classified 
4,373,116 families of 2–5 generations with a mean family 
size of 5.8 persons. Each may have appeared multiple times 
in different categories of family relationships depending on 
the family structure.
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Validation of family relationships
To validate the accuracy of the family identification method, 
we linked the NHI data to the civil registration system gov-
erned by the Ministry of Internal Affairs, which records the 
original data of the birth certificate. We identified 2,171,765 
children born between 2001 and 2014 and found that the 
maternal and paternal links identified by our methods were 
highly consistent with the original birth certificate records. 
The positive predictive value was 98.7% for maternal links 
and 98.6% for paternal links.
ascertainment of type 1 diabetes and 
other autoimmune diseases
In Taiwan, patients with suspected autoimmune diseases 
and severe endocrine diseases are referred to specialists for 
diagnosis and treatment. Patients with diagnoses of type 1 
diabetes and other autoimmune diseases are entitled to a 
waiver for medical co-payments. Clinical information is sent 
to the insurance administration for review by commissioned 
expert panels to confirm the diagnosis before approving such 
waivers. The approval of co-payment waivers for type 1 dia-
betes requires further confirmation of the diagnosis such as 
the presence of autoantibodies. The Registry for Catastrophic 
Illness Patients contains clinical and registration information 
of these patients. We used this registry to identify patients 
with type 1 diabetes mellitus (ICD-9 codes 250.01, 250.03, 
250.11, 250.13, 250.21, 250.23, 250.31, 250.33, 250.41, 
250.43, 250.51, 250.53, 250.61, 250.63, 250.71, 250.73, 
250.81, 250.83, 250.91, and 250.93). Therefore, all patients 
who had type 1 diabetes between 1999 and 2015 and were 
alive in 2015 were identified. The diagnosis of diabetes 
in the NHI database has previously been validated, with a 
positive predictive value of type 1 diabetes of 98.3%.6,20 The 
case definition of type 1 diabetes was also validated by a 
retrospective chart review.
The details of case definitions for other chronic conditions 
are shown in Table S1, and included rheumatoid arthritis, 
Sjögren’s syndrome, systemic lupus erythematosus, systemic 
sclerosis, polymyositis/dermatomyositis, Behçet’s disease, 
vasculitis, inflammatory bowel disease, multiple sclerosis, 
myasthenia gravis, simple goiter, non-toxic nodular goiter, thy-
rotoxicosis, acquired hypothyroidism, thyroiditis, and epilepsy.
Covariates
We considered that age, sex, occupation, income, level of urban-
ization of residence, and family size may have confounded or 
modified the familial associations. Therefore, these factors were 
used as covariates in the estimation of familial RRs.
statistical analysis
The prevalence of type 1 diabetes for the general popula-
tion was calculated as the number of people who were 
alive and diagnosed with type 1 diabetes between 1999 
and 2015 divided by the number of mid-year population in 
Taiwan in 2015. This prevalence estimate was the basis for 
the calculations of heritability and familial transmission. 
The RRs of type 1 diabetes were the adjusted prevalence 
ratios between first-degree relatives of an individual with 
type 1 diabetes and the general population.21 Of the sev-
eral established methods available for the estimation of 
prevalence ratios, we used Breslow–Cox models to estimate 
prevalence rate ratios in a cross-sectional study by setting 
an equal follow-up time for all subjects.22 This method has 
been shown to produce consistent estimates of prevalence 
ratios close to true parameters.23,24 The Breslow–Cox model 
assumes independence between subjects; however, family 
members form natural clusters. Bias caused by within-family 
clustering can be overcome by using the marginal model or 
shared frailty model.25 Previous studies have documented the 
comparability of point estimates and 95% CIs between the 
frailty model25 and marginal model with a robust sandwich 
method.26 In addition, a previous study suggested that the 
marginal model produces a more precise parameter.27 The 
RRs were adjusted for age, sex, socioeconomic factors, and 
family size.28 We fitted the models separately according to 
the kinship and sex of the affected relatives. Twins were 
excluded from the sibling analyses. The RR was estimated 
for the number of affected first-degree kinships. In this 
model, we compared the risk of type 1 diabetes in individu-
als with one or two affected first-degree relatives with the 
general population.
Based on the polygenic liability model,17–19,29 heritabil-
ity was defined as the proportion of phenotypic variance 
attributable to genetic factors, and familial transmission 
was defined as the sum of genetic and shared environmental 
contributions. Familial transmission and heritability can be 
calculated using the polygenic liability model to calculate 
both measures.30–32 As in the original formula developed by 
Reich and Yang,29 we used the population prevalence and 
sibling RR to calculate familial transmission. We further used 
spouses as controls, assuming that they shared the family 
environment but had no genetic similarity with blood family 
members. We could thus calculate heritability, as reported in 
our previous publications.17–19
The extent of familial coaggregation with other chronic 
diseases in the families affected by type 1 diabetes was esti-
mated using a marginal Cox proportional hazards regression 
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model with an equal follow-up time for all subjects adjusting 
for age, sex, place of residence, income level, occupation, and 
family size. RRs were estimated as the adjusted prevalence 
ratio of the specified autoimmune disease between individuals 
with a first-degree relative with type 1 diabetes mellitus and 
those without a family history of type 1 diabetes mellitus. A 
two-sided P-value of less than 0.05 was considered to indicate 
statistical significance. All analyses were performed using 
SAS version 9.4 (SAS Institute, Cary, NC, USA).
Results
The prevalence of type 1 diabetes in 
individuals with affected first-degree 
family members versus the general 
population
We identified 10,723 patients with a diagnosis of type 1 dia-
betes, giving a crude prevalence of 0.04% (Table 1). Women 
had a slightly higher prevalence than men. In the general 
population of Taiwan in 2015, 28,163 (0.12%) individuals 
had at least one first-degree relative with type 1 diabetes, 
including 4,872 with affected parents, 12,493 with affected 
offspring, 10,755 with an affected sibling, and 123 with an 
affected twin. The age-specific prevalence of type 1 diabe-
tes was higher in the individuals with affected first-degree 
relatives with type 1 diabetes than in the general population 
(Figure 1).
relative risks for type 1 diabetes in 
individuals with affected first-degree 
relatives
The prevalence of type 1 diabetes in individuals with affected 
first-degree relatives of specific types is shown in Table 2. The 
RRs (95% CIs) for type 1 diabetes were associated with the 
Figure 1 Age-specific prevalence of type 1 diabetes in individuals with an affected 
first-degree relative and the general population in Taiwan in 2015.
Table 1 Baseline characteristics of the individuals with affected first-degree relatives with type 1 diabetes and the general population
Characteristics Women Men
≥1 Affected 
relative
General population P-value ≥1 Affected 
relative
General population P-value
no 14,339 12,262,442 13,824 12,087,157
age, mean (sD), years 36.73 (17.87) 40.26 (21.02) <0.0001 36.63 (19.14) 38.86 (20.92) <0.0001
Type 1 diabetes, n (%) 227 (1.58) 5,839 (0.05) <0.0001 224 (1.62) 4,884 (0.04) <0.0001
Place of residence, n (%) <0.0001 0.0313
Urban 9,096 (63.44) 7,733,956 (63.07) 8,352 (60.42) 7,308,878 (60.47)
suburban 4,332 (30.21) 3,621,892 (29.54) 4,455 (32.23) 3,848,284 (31.84)
rural 859 (5.99) 871,433 (7.11) 964 (6.97) 895,513 (7.41)
Unknown 52  (0.36) 35,161 (0.29) 53 (0.38) 34,482 (0.29)
income level, n (%) <0.0001 <0.0001
Quintile 1 2,273 (15.85) 2,060,626 (16.80) 2,522 (18.24) 2310294 (19.11)
Quintile 2 2,233 (15.57) 1,837,544 (14.99) 1,729 (12.51) 1506339 (12.46)
Quintile 3 4,191 (29.23) 3655373 (29.81) 3,738 (27.04) 3206535 (26.53)
Quintile 4 3,142 (21.91) 2409990 (19.65) 2,799 (20.25) 2240937 (18.54)
Quintile 5 2,498 (17.42) 2,296,692 (18.73) 3,034 (21.95) 2821233 (23.34)
Unknown 2 (0.01) 2,217 (0.02) 2 (0.01) 1,819 (0.02)
Occupation, n (%) <0.0001 <0.0001
Dependents of the insured 
individuals
5,454 (38.04) 4,531,055 (36.95) 4,712 (34.09) 3,746,218 (30.99)
Civil servants, teachers, military 
personnel, and veterans
402 (2.80) 343,648 (2.80) 731 (5.29) 570,777 (4.72)
non-manual workers and 
professionals
4,489 (31.31) 3,641,661 (29.70) 4,258 (30.80) 3,933,917 (32.55)
Manual workers 2,921 (20.37) 2,606,844 (21.26) 2,674 (19.34) 2,285,790 (18.91)
Other 1,073 (7.48) 1,.139,234 (9.29) 1,449 (10.48) 1,550,455 (12.83)
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degree of genetic distance between family relatives. Overall, 
having an affected co-twin (50% or 100% genetic similarity 
depending on zygosity), first-degree relative (on average 
50% genetic similarity), or spouse (no genetic similarity) 
was associated with adjusted RRs of 553.66 (427.59–716.89), 
32.49 (28.66–36.84), and 2.17 (0.31–15.40), respectively. 
In addition, the RRs increased with the number of types of 
affected first-degree relatives. The individuals with one type 
of affected first-degree relative had an RR (95% CI) of 31.19 
(27.45–35.44), and those with two or more types of affected 
first-degree relatives had an RR of 173.84 (95.63–316.01) 
for type 1 diabetes.
Table 2 Relative risks for type 1 diabetes in first-degree relatives
Type of affected  
relative
Sex of  
affected relative
Sex of the  
individual
No of 
cases
Prevalence (%) Relative risk 
(95% CI)a
Any Male Male 132 2.15 50.01 (39.74–62.93)
Female 98 1.47 27.33 (22.41–33.33)
all 230 1.79 36.97 (31.47–43.42)
Female Male 102 1.31 29.44 (24.12–35.92)
Female 133 1.71 30.97 (24.66–38.90)
all 235 1.51 30.29 (25.91–35.40)
all Male 224 1.62 36.97 (31.59–43.27)
Female 227 1.58 29.00 (24.82–33.88)
all 451 1.60 32.49 (28.66–36.84)
Parent Male Male 15 1.36 25.18 (15.30–41.45)
Female 14 1.36 20.09 (11.99–33.66)
all 29 1.36 22.47 (15.34–32.93)
Female Male 15 1.03 19.43 (11.81–32.00)
Female 16 1.25 19.01 (11.73–30.79)
all 31 1.13 19.18 (13.28–27.71)
all Male 30 1.17 21.93 (15.44–31.16)
Female 30 1.30 19.52 (13.73–27.74)
all 60 1.23 20.65 (15.86–26.89)
Offspring Male Male 15 0.55 22.31 (13.55–36.76)
Female 13 0.41 12.81 (7.46–21.99)
all 28 0.48 16.50 (11.44–23.81)
Female Male 12 0.38 15.12 (8.63–26.49)
Female 15 0.42 12.65 (7.65–20.90)
all 27 0.40 13.60 (9.36–19.76)
all Male 25 0.43 17.19 (11.69–25.30)
Female 26 0.39 11.94 (8.16–17.47)
all 51 0.41 13.98 (10.67–18.33)
Sibling Male Male 78 3.44 58.09 (42.89–78.68)
Female 73 2.92 39.05 (31.22–48.85)
all 151 3.17 47.11 (38.73–57.29)
Female Male 76 2.42 40.1 (31.9–50.3)
Female 81 2.78 36.3 (27.0–48.7)
all 157 2.59 38.1 (31.6–45.9)
all Male 148 2.75 46.07 (38.03–55.81)
Female 154 2.86 37.80 (31.35–45.56)
all 302 2.81 41.50 (35.57–48.43)
Twin Male Male 27 50.00 768.48 (545.83–1081.94)
Female 1 10.00 107.54 (17.37–665.90)
all 28 43.75 640.40 (445.06–921.49)
Female Male 1 6.67 112.76 (17.46–728.21)
Female 21 47.73 557.54 (396.23–784.54)
all 22 37.29 471.47 (328.77–676.10)
all Male 28 40.58 636.13 (446.10–907.12)
Female 22 40.74 468.29 (324.39–676.01)
all 50 40.65 553.66 (427.59–716.89)
Spouse all all 2 0.09 2.17 (0.31–15.40)
Note: aadjusted for age, gender, place of residence, quintile of income level, occupation, and family size.
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Familial resemblance and heritability of 
type 1 diabetes
Using a threshold liability model, we estimated that the 
accountability for phenotypic variance in type 1 diabetes 
was 66.50% for genetic factors (heritability), 10.86% for 
shared environmental factors, and 22.64% for non-shared 
environmental factors.
Coaggregation of other autoimmune 
diseases, thyroid diseases, and epilepsy
We examined the RRs of ten other autoimmune diseases 
(Table 3), three of which (rheumatoid arthritis, Sjögren’s 
syndrome, and systemic lupus erythematosus) showed a 
significant familial coaggregation associated with type 1 
diabetes. A family history of type 1 diabetes was associated 
with thyroid diseases, specifically, a RR (95% CI) of 1.24 
(1.14–1.35) for simple goiter, 1.16 (1.04–1.31) for non-
toxic nodular goiter, 1.61 (1.49–1.74) for thyrotoxicosis, 
1.78 (1.57–2.01) for acquired hypothyroidism, and 1.66 
(1.40–1.98) for thyroiditis. We further tested the coaggrega-
tion of type 1 diabetes with epilepsy, as an association was 
reported in a recent study. However, we found that the RR 
of epilepsy was not significantly increased (RR, 1.15; 95% 
CI, 0.97–1.37) in relatives of people with type 1 diabetes 
compared to the general population (Table 3).
Discussion
This is the first study to report the heritability of type 1 diabetes 
in an East Asian population. Type 1 diabetes was more common 
in people with a family history, and the risk was associated with 
the genetic distance of affected relatives. The familial RR was 
30 times higher than that of individuals with an affected first-
degree relative compared to the general population. We also 
confirmed the strong genetic contribution to type 1 diabetes 
with a heritability of 66.5%, and our results showed that one-
third of phenotypic variance was attributable to environmental 
factors. Furthermore, autoimmune diseases such as rheumatoid 
arthritis and thyroid diseases were more common in people 
with a family history of type 1 diabetes, suggesting that type 
1 diabetes has a strong genetic association or shares common 
pathogenetic roots with autoimmune and thyroid diseases.
Several previous studies have investigated the heritability 
of type 1 diabetes in northern Europe,11,12 with heritability 
estimates ranging from 70% to 88%, which is slightly higher 
than our estimate of 66.5%. A key difference is that we found 
that shared environmental factors also contributed to pheno-
typic variance, whereas no effect was estimated by Hyttinen 
et al.11 We also found significant coaggregation with three 
autoimmune diseases, rheumatoid arthritis, Sjögren’s syn-
drome, and systemic lupus erythematosus, and also a trend 
toward an increased risk of systemic sclerosis, polymyositis/
dermatomyositis, Behçet’s disease, vasculitis, and myasthenia 
gravis in the relatives of the patients with type 1 diabetes. The 
very low prevalence of these disorders in Taiwan means that 
the study may not be powered sufficiently to detect significant 
coaggregation with these disorders. However, a previous 
study found familial coaggregation of type 1 diabetes with 
autoimmune thyroiditis and celiac disease.33 Our data also 
showed that family members of patients with type 1 diabe-
tes tended to have a higher risk of goiter, hypothyroidism, 
and thyroiditis. Therefore, type 1 diabetes probably shares 
pathogenetic roots with autoimmune and thyroid diseases.
Table 3 Relative risks of other diseases in first-degree relatives of patients with type 1 diabetes
Associated conditions With affected relatives General population Relative risk
(95% CI)aNo of cases Prevalence (%) No of cases Prevalence (%)
rheumatoid arthritis 77 0.27 44,103 0.18 1.51 (1.20–1.89)
sjögren’s syndrome 30 0.11 22,652 0.09 1.66 (1.21–2.26)
systemic lupus erythematosus 36 0.13 21,603 0.09 1.48 (1.09–2.01)
systemic sclerosis 4 0.01 2,071 0.01 1.49 (0.56–3.97)
Polymyositis/dermatomyositis 5 0.02 2,113 0.01 1.79 (0.75–4.30)
Behçet’s disease 4 0.01 2,064 0.01 1.38 (0.52–3.67)
Vasculitis 1 0.00 5,044 0.02 0.42 (0.13–1.29)
Inflammatory bowel disease 3 0.01 2,805 0.01 0.81 (0.30–2.14)
Multiple sclerosis 2 0.01 1,586 0.01 0.88 (0.28–2.71)
Myasthenia gravis 11 0.04 7,114 0.03 1.15 (0.62–2.13)
simple goiter 617 2.19 431,452 1.77 1.24 (1.14–1.35)
non-toxic nodular goiter 361 1.28 283,735 1.17 1.16 (1.04–1.31)
Thyrotoxicosis 891 3.16 449,904 1.85 1.61 (1.49–1.74)
acquired hypothyroidism 294 1.04 155,515 0.64 1.78 (1.57–2.01)
Thyroiditis 149 0.53 74,893 0.31 1.66 (1.40–1.98)
Epilepsy 287 1.02 244,967 1.01 1.15 (0.97–1.37)
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We did not find a significant familial coaggregation of type 
1 diabetes with epilepsy, even though the risk of developing 
epilepsy among patients with type 1 diabetes has been shown 
to be ~ 3 times that of the general population both in Taiwan14 
and Europe.15 Moreover, a four- to five-fold increased risk 
of epilepsy has been associated with autoimmune diseases 
in general, and particularly in children.34 The fact that we 
failed to detect any familial coaggregation between type 1 
diabetes and epilepsy, unlike that seen with other autoimmune 
disorders, suggests that epilepsy may be a consequence of 
autoimmune diseases. Our familial aggregation data did not 
support a common etiology, at least not for genetic factors, 
between these two disorders.
There are several limitations to the present study. First, 
the case definition of type 1 diabetes was based purely on 
diagnoses made by physicians. Nevertheless, the accuracy 
of the diagnosis of diabetes in the NHI database has previ-
ously been validated,20 with one previous study reporting a 
positive predictive value of type 1 diabetes in the NHI data-
base of 98.3%.6 Therefore, our case definitions are stringent. 
Second, zygosity of twins is not recorded in the database, 
so we could not estimate heritability using a classic twin 
study design. Instead, we used a population-based design 
to assess the extent of familial aggregation in first-degree 
relatives. Furthermore, we conducted a validation study 
which confirmed the accuracy of our method to reconstruct 
family structure. Third, because we estimated heritability 
using the threshold liability model which assumes that 
underlying liability is normally distributed in the popula-
tion, the results are subject to this assumption. Fourth, 
assortative mating was not considered in our model. If this 
assortment was not negligible, heritability could have been 
underestimated.35 Fifth, this study was restricted to Taiwan, 
and different findings may occur in different populations and 
different environments. Therefore, further studies in other 
countries are required to determine the generalizability of 
our findings.
Conclusion
This nationwide family study suggests that, in Taiwan, a 
family history of type 1 diabetes is one of the strongest 
risk factors for this disease. The differential risk associated 
with different kinships suggests a strong genetic component 
to the susceptibility to type 1 diabetes. A family history 
of type 1 diabetes also exerted an increased risk of other 
autoimmune and thyroid diseases. This may be useful 
information when counseling families with one or more 
affected relatives.
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Supplementary material
Table S1 ICD-9 codes of diseases in first-degree relatives of patients with type 1 diabetes
Diseases ICD-9 code Definition
Type 1 diabetes 250 Catastrophic illness certificates
simple goiter 240 Two outpatient records
non-toxic nodular goiter 241 Two outpatient records
Thyrotoxicosis 242 Two outpatient records
acquired hypothyroidism 244 Two outpatient records
Thyroiditis 245 Two outpatient records
rheumatoid arthritis 7140 Catastrophic illness certificates
sjögren’s syndrome 7102 Catastrophic illness certificates
systemic lupus erythematosus 7100 Catastrophic illness certificates
systemic sclerosis 7101 Catastrophic illness certificates
Polymyositis/dermatomyositis 7103, 7104 Catastrophic illness certificates
Behçet’s disease 1361 Catastrophic illness certificates
Vasculitis 4431, 4460, 4461, 4462, 4464, 4465, 4467 Catastrophic illness certificates
Inflammatory bowel disease 555, 5560, 5561, 5562, 5563, 5564, 5565 5566, 5567, 5568, 5569 Catastrophic illness certificates
Multiple sclerosis 340 Catastrophic illness certificates
Myasthenia gravis 358 Catastrophic illness certificates
Epilepsy 345 Two outpatient records of hospitalization records
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